Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent.

Aim: To determine the minimum effective dose and safety of micafungin in the treatment of HIV-related oesophageal candidiasis.

Method: A total of 120 patients were enrolled in this open label study of the effects of daily 1 h infusions of micafungin on endoscopically proven fungal oesophagitis. Patients were randomly assigned to receive 12.